<--- Back to Details
First PageDocument Content
Norwalk /  Connecticut / International Myeloma Foundation / Multiple myeloma / Multiple Myeloma Research Foundation / University of Arkansas for Medical Sciences / Monoclonal gammopathy of undetermined significance / Celgene / International Myeloma Working Group / Multiple Myeloma Research Consortium / Medicine / Cancer research / Cancer organizations
Date: 2015-03-19 11:33:06
Norwalk
Connecticut
International Myeloma Foundation
Multiple myeloma
Multiple Myeloma Research Foundation
University of Arkansas for Medical Sciences
Monoclonal gammopathy of undetermined significance
Celgene
International Myeloma Working Group
Multiple Myeloma Research Consortium
Medicine
Cancer research
Cancer organizations

A P U B L I C AT I O N O F T H E U A M S M Y E L O M A I N S T I T U T E SPRING 2015 $10 Million Gift Supports Molecular Diagnostics Lab and Endowed Chair “This is an exciting, new

Add to Reading List

Source URL: myeloma.uams.edu

Download Document from Source Website

File Size: 801,80 KB

Share Document on Facebook

Similar Documents

REVIEW  Continuous therapy with lenalidomide in multiple myeloma by Nizar Bahlis, MD

REVIEW Continuous therapy with lenalidomide in multiple myeloma by Nizar Bahlis, MD

DocID: 1aydF - View Document

A P U B L I C AT I O N O F T H E U A M S M Y E L O M A I N S T I T U T E  SPRING 2015 $10 Million Gift Supports Molecular Diagnostics Lab and Endowed Chair “This is an exciting, new

A P U B L I C AT I O N O F T H E U A M S M Y E L O M A I N S T I T U T E SPRING 2015 $10 Million Gift Supports Molecular Diagnostics Lab and Endowed Chair “This is an exciting, new

DocID: 1a3Lt - View Document

continuing education Disclosure of Conflicts of Interest The Nurse Practitioner Healthcare Foundation (NPHF) assesses conflict of interest with its instructors, planners, reviewers, and other individuals who are in a pos

continuing education Disclosure of Conflicts of Interest The Nurse Practitioner Healthcare Foundation (NPHF) assesses conflict of interest with its instructors, planners, reviewers, and other individuals who are in a pos

DocID: 19GZf - View Document

MULTIPLE MYELOMA RESEARCH FOUNDATION DONOR PROGRESS REPORTPOWERFUL THINKING ADVANCES THE CURE

MULTIPLE MYELOMA RESEARCH FOUNDATION DONOR PROGRESS REPORTPOWERFUL THINKING ADVANCES THE CURE

DocID: 12Gxf - View Document

National Chemotherapy Algorithms MULTIPLE MYELOMA SEE MYELOMA – TRANSPLANT ELIGIBLE

National Chemotherapy Algorithms MULTIPLE MYELOMA SEE MYELOMA – TRANSPLANT ELIGIBLE

DocID: 108sO - View Document